0001209191-23-047062.txt : 20230823 0001209191-23-047062.hdr.sgml : 20230823 20230823162840 ACCESSION NUMBER: 0001209191-23-047062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230822 FILED AS OF DATE: 20230823 DATE AS OF CHANGE: 20230823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chudnovsky Yekaterina CENTRAL INDEX KEY: 0001979324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41159 FILM NUMBER: 231197942 MAIL ADDRESS: STREET 1: C/O ELICIO THERAPEUTICS, INC. STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immix Biopharma, Inc. CENTRAL INDEX KEY: 0001873835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454869378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11400 WEST OLYMPIC BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90064 BUSINESS PHONE: (888) 958-1084 MAIL ADDRESS: STREET 1: 10573 W. PICO BLVD. STREET 2: #58 CITY: LOS ANGELES STATE: CA ZIP: 90064 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-22 0 0001873835 Immix Biopharma, Inc. IMMX 0001979324 Chudnovsky Yekaterina C/O IMMIX BIOPHARMA, INC. 11400 WEST OLYMPIC BLVD., SUITE 200 LOS ANGELES CA 90064 1 0 1 0 0 Stock Option (Right to Buy) 1.80 2023-08-22 4 A 0 20000 0.00 A 2033-08-22 Common Stock 20000 20000 D Stock Option (Right to Buy) 1.80 2023-08-22 4 A 0 16670 0.00 A 2033-08-22 Common Stock 16670 16670 D The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors. The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors. /s/ Yekaterina Chudnovsky 2023-08-23